U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

BRCA1 BRCA1 DNA repair associated [ Homo sapiens (human) ]

Gene ID: 672, updated on 25-Sep-2022

Summary

Official Symbol
BRCA1provided by HGNC
Official Full Name
BRCA1 DNA repair associatedprovided by HGNC
Primary source
HGNC:HGNC:1100
See related
Ensembl:ENSG00000012048 MIM:113705; AllianceGenome:HGNC:1100
Gene type
protein coding
RefSeq status
REVIEWED
Organism
Homo sapiens
Lineage
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; Homo
Also known as
IRIS; PSCP; BRCAI; BRCC1; FANCS; PNCA4; RNF53; BROVCA1; PPP1R53
Summary
This gene encodes a 190 kD nuclear phosphoprotein that plays a role in maintaining genomic stability, and it also acts as a tumor suppressor. The BRCA1 gene contains 22 exons spanning about 110 kb of DNA. The encoded protein combines with other tumor suppressors, DNA damage sensors, and signal transducers to form a large multi-subunit protein complex known as the BRCA1-associated genome surveillance complex (BASC). This gene product associates with RNA polymerase II, and through the C-terminal domain, also interacts with histone deacetylase complexes. This protein thus plays a role in transcription, DNA repair of double-stranded breaks, and recombination. Mutations in this gene are responsible for approximately 40% of inherited breast cancers and more than 80% of inherited breast and ovarian cancers. Alternative splicing plays a role in modulating the subcellular localization and physiological function of this gene. Many alternatively spliced transcript variants, some of which are disease-associated mutations, have been described for this gene, but the full-length natures of only some of these variants has been described. A related pseudogene, which is also located on chromosome 17, has been identified. [provided by RefSeq, May 2020]
Expression
Broad expression in testis (RPKM 5.2), lymph node (RPKM 3.3) and 23 other tissues See more
Orthologs
NEW
Try the new Gene table
Try the new Transcript table

Genomic context

See BRCA1 in Genome Data Viewer
Location:
17q21.31
Exon count:
24
Annotation release Status Assembly Chr Location
110 current GRCh38.p14 (GCF_000001405.40) 17 NC_000017.11 (43044295..43125364, complement)
110 current T2T-CHM13v2.0 (GCF_009914755.1) 17 NC_060941.1 (43902857..43983996, complement)
105.20220307 previous assembly GRCh37.p13 (GCF_000001405.25) 17 NC_000017.10 (41196312..41277381, complement)

Chromosome 17 - NC_000017.11Genomic Context describing neighboring genes Neighboring gene vesicle amine transport 1 Neighboring gene Rho family GTPase 2 Neighboring gene ribosomal protein L21 pseudogene 4 Neighboring gene BRCA1 intronic recombination region Neighboring gene BRCA1 intron 2 regulatory region Neighboring gene BRCA1 promoter region Neighboring gene neighbor of BRCA1 lncRNA 2 Neighboring gene uncharacterized LOC101929767 Neighboring gene high mobility group nucleosome binding domain 1 pseudogene 29 Neighboring gene BRCA1P1 intergenic recombination region

Genomic regions, transcripts, and products

Expression

  • Project title: HPA RNA-seq normal tissues
  • Description: RNA-seq was performed of tissue samples from 95 human individuals representing 27 different tissues in order to determine tissue-specificity of all protein-coding genes
  • BioProject: PRJEB4337
  • Publication: PMID 24309898
  • Analysis date: Wed Apr 4 07:08:55 2018

Bibliography

GeneRIFs: Gene References Into Functions

What's a GeneRIF?

Phenotypes

Professional guidelines

Description
Professional guideline
ACMG 2013

The ACMG recommends that laboratories performing clinical sequencing seek and report mutations in BRCA1 that are pathogenic or expected to be pathogenic.

GuidelinePubMed

Copy number response

Description
Copy number response
Triplosensitivity

No evidence available (Last evaluated 2021-09-23)

ClinGen Genome Curation Page
Haploinsufficency

Sufficient evidence for dosage pathogenicity (Last evaluated 2021-09-23)

ClinGen Genome Curation PagePubMed

HIV-1 interactions

Replication interactions

Interaction Pubs
Knockdown of breast cancer 1, early onset (BRCA1) by siRNA inhibits HIV-1 replication in HeLa P4/R5 cells PubMed

Protein interactions

Protein Gene Interaction Pubs
Tat tat HIV-1 Tat associates with BRCA1 in cells and the amino-acid 504-802 region of BRCA1 physically interacts with HIV-1 Tat PubMed
tat BRCA1 enhances HIV-1 Tat-dependent transcription in cells, and BRCA1 phosphorylation at positions S1387, S1423, S1457, and S1524 is important for the enhancement of Tat-dependent transcription PubMed
Vpr vpr HIV-1 Vpr stimulates the focus formation of Rad51 and BRCA1, which are involved in repair of DNA double-strand breaks (DSBs) by homologous recombination (HR) PubMed
vpr HIV-1 Vpr induces phosphorylation of BRCA1 at serine 1423 in an ATR-dependent manner PubMed
vpr HIV-1 Vpr expression in HeLa cells induces formation of nuclear foci containing H2AFX and BRCA1 PubMed

Go to the HIV-1, Human Interaction Database

Pathways from PubChem

Interactions

Products Interactant Other Gene Complex Source Pubs Description

General gene information

Markers

Homology

Gene Ontology Provided by GOA

Function Evidence Code Pubs
enables DNA binding TAS
Traceable Author Statement
more info
PubMed 
enables RNA binding IDA
Inferred from Direct Assay
more info
PubMed 
enables RNA polymerase binding IDA
Inferred from Direct Assay
more info
PubMed 
enables damaged DNA binding IEA
Inferred from Electronic Annotation
more info
 
enables enzyme binding IPI
Inferred from Physical Interaction
more info
PubMed 
enables identical protein binding IPI
Inferred from Physical Interaction
more info
PubMed 
enables p53 binding IDA
Inferred from Direct Assay
more info
PubMed 
enables protein binding IPI
Inferred from Physical Interaction
more info
PubMed 
enables transcription cis-regulatory region binding IDA
Inferred from Direct Assay
more info
PubMed 
enables transcription coactivator activity IMP
Inferred from Mutant Phenotype
more info
PubMed 
enables tubulin binding NAS
Non-traceable Author Statement
more info
PubMed 
enables ubiquitin protein ligase binding IPI
Inferred from Physical Interaction
more info
PubMed 
enables ubiquitin-protein transferase activity IBA
Inferred from Biological aspect of Ancestor
more info
PubMed 
enables ubiquitin-protein transferase activity IDA
Inferred from Direct Assay
more info
PubMed 
enables ubiquitin-protein transferase activity TAS
Traceable Author Statement
more info
 
enables zinc ion binding IEA
Inferred from Electronic Annotation
more info
 
Process Evidence Code Pubs
involved_in DNA repair IC
Inferred by Curator
more info
PubMed 
involved_in DNA strand resection involved in replication fork processing IC
Inferred by Curator
more info
PubMed 
involved_in cellular response to DNA damage stimulus IC
Inferred by Curator
more info
PubMed 
involved_in cellular response to indole-3-methanol IDA
Inferred from Direct Assay
more info
PubMed 
involved_in cellular response to ionizing radiation IMP
Inferred from Mutant Phenotype
more info
PubMed 
involved_in cellular response to tumor necrosis factor IMP
Inferred from Mutant Phenotype
more info
PubMed 
involved_in centrosome cycle IEA
Inferred from Electronic Annotation
more info
 
involved_in chordate embryonic development IBA
Inferred from Biological aspect of Ancestor
more info
PubMed 
involved_in chromosome segregation IMP
Inferred from Mutant Phenotype
more info
PubMed 
involved_in dosage compensation by inactivation of X chromosome IBA
Inferred from Biological aspect of Ancestor
more info
PubMed 
involved_in double-strand break repair IDA
Inferred from Direct Assay
more info
PubMed 
involved_in double-strand break repair IMP
Inferred from Mutant Phenotype
more info
PubMed 
involved_in double-strand break repair TAS
Traceable Author Statement
more info
 
involved_in double-strand break repair via homologous recombination IBA
Inferred from Biological aspect of Ancestor
more info
PubMed 
involved_in double-strand break repair via homologous recombination IDA
Inferred from Direct Assay
more info
PubMed 
involved_in fatty acid biosynthetic process IEA
Inferred from Electronic Annotation
more info
 
involved_in histone H2A K63-linked deubiquitination IC
Inferred by Curator
more info
PubMed 
involved_in histone H2A monoubiquitination IC
Inferred by Curator
more info
PubMed 
involved_in homologous recombination IC
Inferred by Curator
more info
PubMed 
acts_upstream_of_or_within intrinsic apoptotic signaling pathway in response to DNA damage IDA
Inferred from Direct Assay
more info
PubMed 
involved_in localization IDA
Inferred from Direct Assay
more info
PubMed 
involved_in mitotic G2 DNA damage checkpoint signaling IMP
Inferred from Mutant Phenotype
more info
PubMed 
involved_in mitotic G2/M transition checkpoint IC
Inferred by Curator
more info
PubMed 
involved_in negative regulation of DNA-templated transcription IDA
Inferred from Direct Assay
more info
PubMed 
involved_in negative regulation of cell cycle IC
Inferred by Curator
more info
PubMed 
involved_in negative regulation of cell growth IMP
Inferred from Mutant Phenotype
more info
PubMed 
involved_in negative regulation of centriole replication NAS
Non-traceable Author Statement
more info
PubMed 
involved_in negative regulation of extrinsic apoptotic signaling pathway via death domain receptors IMP
Inferred from Mutant Phenotype
more info
PubMed 
involved_in negative regulation of fatty acid biosynthetic process IBA
Inferred from Biological aspect of Ancestor
more info
PubMed 
involved_in negative regulation of fatty acid biosynthetic process IMP
Inferred from Mutant Phenotype
more info
PubMed 
involved_in negative regulation of histone H3-K4 methylation IEA
Inferred from Electronic Annotation
more info
 
involved_in negative regulation of histone H3-K9 methylation IDA
Inferred from Direct Assay
more info
PubMed 
involved_in negative regulation of histone acetylation IBA
Inferred from Biological aspect of Ancestor
more info
PubMed 
involved_in negative regulation of intracellular estrogen receptor signaling pathway IMP
Inferred from Mutant Phenotype
more info
PubMed 
involved_in negative regulation of reactive oxygen species metabolic process IMP
Inferred from Mutant Phenotype
more info
PubMed 
involved_in positive regulation of DNA repair IMP
Inferred from Mutant Phenotype
more info
PubMed 
involved_in positive regulation of DNA-templated transcription IDA
Inferred from Direct Assay
more info
PubMed 
involved_in positive regulation of DNA-templated transcription IMP
Inferred from Mutant Phenotype
more info
PubMed 
involved_in positive regulation of angiogenesis IMP
Inferred from Mutant Phenotype
more info
PubMed 
involved_in positive regulation of gene expression IMP
Inferred from Mutant Phenotype
more info
PubMed 
involved_in positive regulation of histone H3-K4 methylation IDA
Inferred from Direct Assay
more info
PubMed 
involved_in positive regulation of histone H3-K9 acetylation IDA
Inferred from Direct Assay
more info
PubMed 
involved_in positive regulation of histone H3-K9 methylation IEA
Inferred from Electronic Annotation
more info
 
involved_in positive regulation of histone H4-K16 acetylation IDA
Inferred from Direct Assay
more info
PubMed 
involved_in positive regulation of histone H4-K20 methylation IDA
Inferred from Direct Assay
more info
PubMed 
involved_in positive regulation of histone acetylation IBA
Inferred from Biological aspect of Ancestor
more info
PubMed 
involved_in positive regulation of histone acetylation IDA
Inferred from Direct Assay
more info
PubMed 
involved_in positive regulation of protein ubiquitination IDA
Inferred from Direct Assay
more info
PubMed 
involved_in positive regulation of transcription by RNA polymerase II IBA
Inferred from Biological aspect of Ancestor
more info
PubMed 
involved_in positive regulation of transcription by RNA polymerase II IDA
Inferred from Direct Assay
more info
PubMed 
involved_in positive regulation of transcription by RNA polymerase II IMP
Inferred from Mutant Phenotype
more info
PubMed 
involved_in positive regulation of vascular endothelial growth factor production IMP
Inferred from Mutant Phenotype
more info
PubMed 
involved_in postreplication repair IDA
Inferred from Direct Assay
more info
PubMed 
involved_in protein K6-linked ubiquitination IDA
Inferred from Direct Assay
more info
PubMed 
involved_in protein autoubiquitination IC
Inferred by Curator
more info
PubMed 
involved_in protein autoubiquitination IDA
Inferred from Direct Assay
more info
PubMed 
involved_in protein polyubiquitination IDA
Inferred from Direct Assay
more info
PubMed 
involved_in protein ubiquitination IDA
Inferred from Direct Assay
more info
PubMed 
involved_in regulation of DNA damage checkpoint IC
Inferred by Curator
more info
PubMed 
involved_in regulation of DNA methylation IEA
Inferred from Electronic Annotation
more info
 
involved_in regulation of DNA repair IC
Inferred by Curator
more info
PubMed 
acts_upstream_of regulation of cell cycle IDA
Inferred from Direct Assay
more info
PubMed 
involved_in regulation of gene expression by genomic imprinting IEA
Inferred from Electronic Annotation
more info
 
involved_in regulation of transcription by RNA polymerase II IMP
Inferred from Mutant Phenotype
more info
PubMed 
involved_in response to estrogen IDA
Inferred from Direct Assay
more info
PubMed 
involved_in response to ionizing radiation IMP
Inferred from Mutant Phenotype
more info
PubMed 
Component Evidence Code Pubs
part_of BRCA1-A complex IBA
Inferred from Biological aspect of Ancestor
more info
PubMed 
part_of BRCA1-A complex IC
Inferred by Curator
more info
PubMed 
part_of BRCA1-A complex IDA
Inferred from Direct Assay
more info
PubMed 
part_of BRCA1-B complex IPI
Inferred from Physical Interaction
more info
PubMed 
part_of BRCA1-BARD1 complex IBA
Inferred from Biological aspect of Ancestor
more info
PubMed 
part_of BRCA1-BARD1 complex IDA
Inferred from Direct Assay
more info
PubMed 
part_of BRCA1-BARD1 complex IPI
Inferred from Physical Interaction
more info
PubMed 
part_of BRCA1-C complex IPI
Inferred from Physical Interaction
more info
PubMed 
part_of DNA repair complex IPI
Inferred from Physical Interaction
more info
PubMed 
located_in XY body IEA
Inferred from Electronic Annotation
more info
 
located_in chromosome ISS
Inferred from Sequence or Structural Similarity
more info
 
located_in cytoplasm IDA
Inferred from Direct Assay
more info
PubMed 
part_of gamma-tubulin ring complex NAS
Non-traceable Author Statement
more info
PubMed 
is_active_in intracellular non-membrane-bounded organelle IDA
Inferred from Direct Assay
more info
PubMed 
located_in lateral element IDA
Inferred from Direct Assay
more info
PubMed 
located_in male germ cell nucleus IEA
Inferred from Electronic Annotation
more info
 
located_in nuclear body IDA
Inferred from Direct Assay
more info
 
part_of nuclear ubiquitin ligase complex IDA
Inferred from Direct Assay
more info
PubMed 
located_in nucleoplasm IDA
Inferred from Direct Assay
more info
 
located_in nucleoplasm TAS
Traceable Author Statement
more info
 
located_in nucleus IC
Inferred by Curator
more info
PubMed 
located_in nucleus IDA
Inferred from Direct Assay
more info
PubMed 
is_active_in plasma membrane IBA
Inferred from Biological aspect of Ancestor
more info
PubMed 
located_in plasma membrane IDA
Inferred from Direct Assay
more info
PubMed 
part_of protein-containing complex IDA
Inferred from Direct Assay
more info
PubMed 
part_of ribonucleoprotein complex IDA
Inferred from Direct Assay
more info
PubMed 
part_of ubiquitin ligase complex NAS
Non-traceable Author Statement
more info
PubMed 

General protein information

Preferred Names
breast cancer type 1 susceptibility protein
Names
BRCA1/BRCA2-containing complex, subunit 1
Fanconi anemia, complementation group S
RING finger protein 53
breast and ovarian cancer susceptibility protein 1
breast cancer 1, early onset
early onset breast cancer 1
protein phosphatase 1, regulatory subunit 53
NP_009225.1
NP_009228.2
NP_009229.2
NP_009230.2
NP_009231.2

NCBI Reference Sequences (RefSeq)

NEW Try the new Transcript table

RefSeqs maintained independently of Annotated Genomes

These reference sequences exist independently of genome builds. Explain

These reference sequences are curated independently of the genome annotation cycle, so their versions may not match the RefSeq versions in the current genome build. Identify version mismatches by comparing the version of the RefSeq in this section to the one reported in Genomic regions, transcripts, and products above.

Genomic

  1. NG_005905.2 RefSeqGene

    Range
    92501..173689
    Download
    GenBank, FASTA, Sequence Viewer (Graphics), LRG_292

mRNA and Protein(s)

  1. NM_001407571.1NP_001394500.1  breast cancer type 1 susceptibility protein isoform 6

    Status: REVIEWED

    Source sequence(s)
    AC135721
  2. NM_001407581.1NP_001394510.1  breast cancer type 1 susceptibility protein isoform 7

    Status: REVIEWED

    Source sequence(s)
    AC135721
  3. NM_001407582.1NP_001394511.1  breast cancer type 1 susceptibility protein isoform 7

    Status: REVIEWED

    Source sequence(s)
    AC135721
  4. NM_001407583.1NP_001394512.1  breast cancer type 1 susceptibility protein isoform 2

    Status: REVIEWED

    Source sequence(s)
    AC135721
  5. NM_001407585.1NP_001394514.1  breast cancer type 1 susceptibility protein isoform 2

    Status: REVIEWED

    Source sequence(s)
    AC135721
  6. NM_001407587.1NP_001394516.1  breast cancer type 1 susceptibility protein isoform 8

    Status: REVIEWED

    Source sequence(s)
    AC135721
  7. NM_001407590.1NP_001394519.1  breast cancer type 1 susceptibility protein isoform 9

    Status: REVIEWED

    Source sequence(s)
    AC135721
  8. NM_001407591.1NP_001394520.1  breast cancer type 1 susceptibility protein isoform 9

    Status: REVIEWED

    Source sequence(s)
    AC135721
  9. NM_001407593.1NP_001394522.1  breast cancer type 1 susceptibility protein isoform 1

    Status: REVIEWED

    Source sequence(s)
    AC135721
    UniProtKB/Swiss-Prot
    Q7KYU9
  10. NM_001407594.1NP_001394523.1  breast cancer type 1 susceptibility protein isoform 1

    Status: REVIEWED

    Source sequence(s)
    AC135721
    UniProtKB/Swiss-Prot
    Q7KYU9
  11. NM_001407596.1NP_001394525.1  breast cancer type 1 susceptibility protein isoform 1

    Status: REVIEWED

    Source sequence(s)
    AC135721
    UniProtKB/Swiss-Prot
    Q7KYU9
  12. NM_001407597.1NP_001394526.1  breast cancer type 1 susceptibility protein isoform 1

    Status: REVIEWED

    Source sequence(s)
    AC135721
    UniProtKB/Swiss-Prot
    Q7KYU9
  13. NM_001407598.1NP_001394527.1  breast cancer type 1 susceptibility protein isoform 1

    Status: REVIEWED

    Source sequence(s)
    AC135721
    UniProtKB/Swiss-Prot
    Q7KYU9
  14. NM_001407602.1NP_001394531.1  breast cancer type 1 susceptibility protein isoform 1

    Status: REVIEWED

    Source sequence(s)
    AC135721
    UniProtKB/Swiss-Prot
    Q7KYU9
  15. NM_001407603.1NP_001394532.1  breast cancer type 1 susceptibility protein isoform 1

    Status: REVIEWED

    Source sequence(s)
    AC135721
    UniProtKB/Swiss-Prot
    Q7KYU9
  16. NM_001407605.1NP_001394534.1  breast cancer type 1 susceptibility protein isoform 1

    Status: REVIEWED

    Source sequence(s)
    AC135721
    UniProtKB/Swiss-Prot
    Q7KYU9
  17. NM_001407610.1NP_001394539.1  breast cancer type 1 susceptibility protein isoform 10

    Status: REVIEWED

    Source sequence(s)
    AC135721
  18. NM_001407611.1NP_001394540.1  breast cancer type 1 susceptibility protein isoform 10

    Status: REVIEWED

    Source sequence(s)
    AC135721
  19. NM_001407612.1NP_001394541.1  breast cancer type 1 susceptibility protein isoform 10

    Status: REVIEWED

    Source sequence(s)
    AC135721
  20. NM_001407613.1NP_001394542.1  breast cancer type 1 susceptibility protein isoform 10

    Status: REVIEWED

    Source sequence(s)
    AC135721
  21. NM_001407614.1NP_001394543.1  breast cancer type 1 susceptibility protein isoform 10

    Status: REVIEWED

    Source sequence(s)
    AC135721
  22. NM_001407615.1NP_001394544.1  breast cancer type 1 susceptibility protein isoform 10

    Status: REVIEWED

    Source sequence(s)
    AC135721
  23. NM_001407616.1NP_001394545.1  breast cancer type 1 susceptibility protein isoform 11

    Status: REVIEWED

    Source sequence(s)
    AC135721
  24. NM_001407617.1NP_001394546.1  breast cancer type 1 susceptibility protein isoform 11

    Status: REVIEWED

    Source sequence(s)
    AC135721
  25. NM_001407618.1NP_001394547.1  breast cancer type 1 susceptibility protein isoform 11

    Status: REVIEWED

    Source sequence(s)
    AC135721
  26. NM_001407619.1NP_001394548.1  breast cancer type 1 susceptibility protein isoform 11

    Status: REVIEWED

    Source sequence(s)
    AC135721
  27. NM_001407620.1NP_001394549.1  breast cancer type 1 susceptibility protein isoform 11

    Status: REVIEWED

    Source sequence(s)
    AC135721
  28. NM_001407621.1NP_001394550.1  breast cancer type 1 susceptibility protein isoform 11

    Status: REVIEWED

    Source sequence(s)
    AC135721
  29. NM_001407622.1NP_001394551.1  breast cancer type 1 susceptibility protein isoform 11

    Status: REVIEWED

    Source sequence(s)
    AC135721
  30. NM_001407623.1NP_001394552.1  breast cancer type 1 susceptibility protein isoform 11

    Status: REVIEWED

    Source sequence(s)
    AC135721
  31. NM_001407624.1NP_001394553.1  breast cancer type 1 susceptibility protein isoform 12

    Status: REVIEWED

    Source sequence(s)
    AC135721
  32. NM_001407625.1NP_001394554.1  breast cancer type 1 susceptibility protein isoform 12

    Status: REVIEWED

    Source sequence(s)
    AC135721
  33. NM_001407626.1NP_001394555.1  breast cancer type 1 susceptibility protein isoform 12

    Status: REVIEWED

    Source sequence(s)
    AC135721
  34. NM_001407627.1NP_001394556.1  breast cancer type 1 susceptibility protein isoform 13

    Status: REVIEWED

    Source sequence(s)
    AC135721
  35. NM_001407628.1NP_001394557.1  breast cancer type 1 susceptibility protein isoform 13

    Status: REVIEWED

    Source sequence(s)
    AC135721
  36. NM_001407629.1NP_001394558.1  breast cancer type 1 susceptibility protein isoform 13

    Status: REVIEWED

    Source sequence(s)
    AC135721
  37. NM_001407630.1NP_001394559.1  breast cancer type 1 susceptibility protein isoform 13

    Status: REVIEWED

    Source sequence(s)
    AC135721
  38. NM_001407631.1NP_001394560.1  breast cancer type 1 susceptibility protein isoform 13

    Status: REVIEWED

    Source sequence(s)
    AC135721
  39. NM_001407632.1NP_001394561.1  breast cancer type 1 susceptibility protein isoform 13

    Status: REVIEWED

    Source sequence(s)
    AC135721
  40. NM_001407633.1NP_001394562.1  breast cancer type 1 susceptibility protein isoform 14

    Status: REVIEWED

    Source sequence(s)
    AC135721
  41. NM_001407634.1NP_001394563.1  breast cancer type 1 susceptibility protein isoform 14

    Status: REVIEWED

    Source sequence(s)
    AC135721
  42. NM_001407635.1NP_001394564.1  breast cancer type 1 susceptibility protein isoform 14

    Status: REVIEWED

    Source sequence(s)
    AC135721
  43. NM_001407636.1NP_001394565.1  breast cancer type 1 susceptibility protein isoform 14

    Status: REVIEWED

    Source sequence(s)
    AC135721
  44. NM_001407637.1NP_001394566.1  breast cancer type 1 susceptibility protein isoform 14

    Status: REVIEWED

    Source sequence(s)
    AC135721
  45. NM_001407638.1NP_001394567.1  breast cancer type 1 susceptibility protein isoform 14

    Status: REVIEWED

    Source sequence(s)
    AC135721
  46. NM_001407639.1NP_001394568.1  breast cancer type 1 susceptibility protein isoform 15

    Status: REVIEWED

    Source sequence(s)
    AC135721
  47. NM_001407640.1NP_001394569.1  breast cancer type 1 susceptibility protein isoform 15

    Status: REVIEWED

    Source sequence(s)
    AC135721
  48. NM_001407641.1NP_001394570.1  breast cancer type 1 susceptibility protein isoform 15

    Status: REVIEWED

    Source sequence(s)
    AC135721
  49. NM_001407642.1NP_001394571.1  breast cancer type 1 susceptibility protein isoform 15

    Status: REVIEWED

    Source sequence(s)
    AC135721
  50. NM_001407644.1NP_001394573.1  breast cancer type 1 susceptibility protein isoform 16

    Status: REVIEWED

    Source sequence(s)
    AC135721
  51. NM_001407645.1NP_001394574.1  breast cancer type 1 susceptibility protein isoform 16

    Status: REVIEWED

    Source sequence(s)
    AC135721
  52. NM_001407646.1NP_001394575.1  breast cancer type 1 susceptibility protein isoform 17

    Status: REVIEWED

    Source sequence(s)
    AC135721
  53. NM_001407647.1NP_001394576.1  breast cancer type 1 susceptibility protein isoform 18

    Status: REVIEWED

    Source sequence(s)
    AC135721
  54. NM_001407648.1NP_001394577.1  breast cancer type 1 susceptibility protein isoform 19

    Status: REVIEWED

    Source sequence(s)
    AC135721
  55. NM_001407649.1NP_001394578.1  breast cancer type 1 susceptibility protein isoform 20

    Status: REVIEWED

    Source sequence(s)
    AC135721
  56. NM_001407652.1NP_001394581.1  breast cancer type 1 susceptibility protein isoform 21

    Status: REVIEWED

    Source sequence(s)
    AC135721
  57. NM_001407653.1NP_001394582.1  breast cancer type 1 susceptibility protein isoform 22

    Status: REVIEWED

    Source sequence(s)
    AC135721
  58. NM_001407654.1NP_001394583.1  breast cancer type 1 susceptibility protein isoform 22

    Status: REVIEWED

    Source sequence(s)
    AC135721
  59. NM_001407655.1NP_001394584.1  breast cancer type 1 susceptibility protein isoform 22

    Status: REVIEWED

    Source sequence(s)
    AC135721
  60. NM_001407656.1NP_001394585.1  breast cancer type 1 susceptibility protein isoform 23

    Status: REVIEWED

    Source sequence(s)
    AC135721
  61. NM_001407657.1NP_001394586.1  breast cancer type 1 susceptibility protein isoform 24

    Status: REVIEWED

    Source sequence(s)
    AC135721
  62. NM_001407658.1NP_001394587.1  breast cancer type 1 susceptibility protein isoform 24

    Status: REVIEWED

    Source sequence(s)
    AC135721
  63. NM_001407659.1NP_001394588.1  breast cancer type 1 susceptibility protein isoform 25

    Status: REVIEWED

    Source sequence(s)
    AC135721
  64. NM_001407660.1NP_001394589.1  breast cancer type 1 susceptibility protein isoform 25

    Status: REVIEWED

    Source sequence(s)
    AC135721
  65. NM_001407661.1NP_001394590.1  breast cancer type 1 susceptibility protein isoform 26

    Status: REVIEWED

    Source sequence(s)
    AC135721
  66. NM_001407662.1NP_001394591.1  breast cancer type 1 susceptibility protein isoform 26

    Status: REVIEWED

    Source sequence(s)
    AC135721
  67. NM_001407663.1NP_001394592.1  breast cancer type 1 susceptibility protein isoform 93

    Status: REVIEWED

    Source sequence(s)
    AC135721
  68. NM_001407664.1NP_001394593.1  breast cancer type 1 susceptibility protein isoform 27

    Status: REVIEWED

    Source sequence(s)
    AC135721
  69. NM_001407665.1NP_001394594.1  breast cancer type 1 susceptibility protein isoform 27

    Status: REVIEWED

    Source sequence(s)
    AC135721
  70. NM_001407666.1NP_001394595.1  breast cancer type 1 susceptibility protein isoform 27

    Status: REVIEWED

    Source sequence(s)
    AC135721
  71. NM_001407667.1NP_001394596.1  breast cancer type 1 susceptibility protein isoform 27

    Status: REVIEWED

    Source sequence(s)
    AC135721
  72. NM_001407668.1NP_001394597.1  breast cancer type 1 susceptibility protein isoform 27

    Status: REVIEWED

    Source sequence(s)
    AC135721
  73. NM_001407669.1NP_001394598.1  breast cancer type 1 susceptibility protein isoform 27

    Status: REVIEWED

    Source sequence(s)
    AC135721
  74. NM_001407670.1NP_001394599.1  breast cancer type 1 susceptibility protein isoform 28

    Status: REVIEWED

    Source sequence(s)
    AC135721
  75. NM_001407671.1NP_001394600.1  breast cancer type 1 susceptibility protein isoform 28

    Status: REVIEWED

    Source sequence(s)
    AC135721
  76. NM_001407672.1NP_001394601.1  breast cancer type 1 susceptibility protein isoform 28

    Status: REVIEWED

    Source sequence(s)
    AC135721
  77. NM_001407673.1NP_001394602.1  breast cancer type 1 susceptibility protein isoform 28

    Status: REVIEWED

    Source sequence(s)
    AC135721
  78. NM_001407674.1NP_001394603.1  breast cancer type 1 susceptibility protein isoform 29

    Status: REVIEWED

    Source sequence(s)
    AC135721
  79. NM_001407675.1NP_001394604.1  breast cancer type 1 susceptibility protein isoform 29

    Status: REVIEWED

    Source sequence(s)
    AC135721
  80. NM_001407676.1NP_001394605.1  breast cancer type 1 susceptibility protein isoform 29

    Status: REVIEWED

    Source sequence(s)
    AC135721
  81. NM_001407677.1NP_001394606.1  breast cancer type 1 susceptibility protein isoform 30

    Status: REVIEWED

    Source sequence(s)
    AC135721
  82. NM_001407678.1NP_001394607.1  breast cancer type 1 susceptibility protein isoform 30

    Status: REVIEWED

    Source sequence(s)
    AC135721
  83. NM_001407679.1NP_001394608.1  breast cancer type 1 susceptibility protein isoform 30

    Status: REVIEWED

    Source sequence(s)
    AC135721
  84. NM_001407680.1NP_001394609.1  breast cancer type 1 susceptibility protein isoform 30

    Status: REVIEWED

    Source sequence(s)
    AC135721
  85. NM_001407681.1NP_001394610.1  breast cancer type 1 susceptibility protein isoform 31

    Status: REVIEWED

    Source sequence(s)
    AC135721
  86. NM_001407682.1NP_001394611.1  breast cancer type 1 susceptibility protein isoform 31

    Status: REVIEWED

    Source sequence(s)
    AC135721
  87. NM_001407683.1NP_001394612.1  breast cancer type 1 susceptibility protein isoform 31

    Status: REVIEWED

    Source sequence(s)
    AC135721
  88. NM_001407684.1NP_001394613.1  breast cancer type 1 susceptibility protein isoform 32

    Status: REVIEWED

    Source sequence(s)
    AC135721
  89. NM_001407685.1NP_001394614.1  breast cancer type 1 susceptibility protein isoform 33

    Status: REVIEWED

    Source sequence(s)
    AC135721
  90. NM_001407686.1NP_001394615.1  breast cancer type 1 susceptibility protein isoform 33

    Status: REVIEWED

    Source sequence(s)
    AC135721
  91. NM_001407687.1NP_001394616.1  breast cancer type 1 susceptibility protein isoform 33

    Status: REVIEWED

    Source sequence(s)
    AC135721
  92. NM_001407688.1NP_001394617.1  breast cancer type 1 susceptibility protein isoform 34

    Status: REVIEWED

    Source sequence(s)
    AC135721
  93. NM_001407689.1NP_001394618.1  breast cancer type 1 susceptibility protein isoform 34

    Status: REVIEWED

    Source sequence(s)
    AC135721
  94. NM_001407690.1NP_001394619.1  breast cancer type 1 susceptibility protein isoform 35

    Status: REVIEWED

    Source sequence(s)
    AC135721
  95. NM_001407691.1NP_001394620.1  breast cancer type 1 susceptibility protein isoform 35

    Status: REVIEWED

    Source sequence(s)
    AC135721
  96. NM_001407692.1NP_001394621.1  breast cancer type 1 susceptibility protein isoform 3

    Status: REVIEWED

    Source sequence(s)
    AC135721
  97. NM_001407694.1NP_001394623.1  breast cancer type 1 susceptibility protein isoform 3

    Status: REVIEWED

    Source sequence(s)
    AC135721
  98. NM_001407695.1NP_001394624.1  breast cancer type 1 susceptibility protein isoform 3

    Status: REVIEWED

    Source sequence(s)
    AC135721
  99. NM_001407696.1NP_001394625.1  breast cancer type 1 susceptibility protein isoform 3

    Status: REVIEWED

    Source sequence(s)
    AC135721
  100. NM_001407697.1NP_001394626.1  breast cancer type 1 susceptibility protein isoform 3

    Status: REVIEWED

    Source sequence(s)
    AC135721
  101. NM_001407698.1NP_001394627.1  breast cancer type 1 susceptibility protein isoform 3

    Status: REVIEWED

    Source sequence(s)
    AC135721
  102. NM_001407724.1NP_001394653.1  breast cancer type 1 susceptibility protein isoform 3

    Status: REVIEWED

    Source sequence(s)
    AC135721
  103. NM_001407725.1NP_001394654.1  breast cancer type 1 susceptibility protein isoform 3

    Status: REVIEWED

    Source sequence(s)
    AC135721
  104. NM_001407726.1NP_001394655.1  breast cancer type 1 susceptibility protein isoform 3

    Status: REVIEWED

    Source sequence(s)
    AC135721
  105. NM_001407727.1NP_001394656.1  breast cancer type 1 susceptibility protein isoform 3

    Status: REVIEWED

    Source sequence(s)
    AC135721
  106. NM_001407728.1NP_001394657.1  breast cancer type 1 susceptibility protein isoform 3

    Status: REVIEWED

    Source sequence(s)
    AC135721
  107. NM_001407729.1NP_001394658.1  breast cancer type 1 susceptibility protein isoform 3

    Status: REVIEWED

    Source sequence(s)
    AC135721
  108. NM_001407730.1NP_001394659.1  breast cancer type 1 susceptibility protein isoform 3

    Status: REVIEWED

    Source sequence(s)
    AC135721
  109. NM_001407731.1NP_001394660.1  breast cancer type 1 susceptibility protein isoform 3

    Status: REVIEWED

    Source sequence(s)
    AC135721
  110. NM_001407732.1NP_001394661.1  breast cancer type 1 susceptibility protein isoform 36

    Status: REVIEWED

    Source sequence(s)
    AC135721
  111. NM_001407733.1NP_001394662.1  breast cancer type 1 susceptibility protein isoform 36

    Status: REVIEWED

    Source sequence(s)
    AC135721
  112. NM_001407734.1NP_001394663.1  breast cancer type 1 susceptibility protein isoform 36

    Status: REVIEWED

    Source sequence(s)
    AC135721
  113. NM_001407735.1NP_001394664.1  breast cancer type 1 susceptibility protein isoform 36

    Status: REVIEWED

    Source sequence(s)
    AC135721
  114. NM_001407736.1NP_001394665.1  breast cancer type 1 susceptibility protein isoform 36

    Status: REVIEWED

    Source sequence(s)
    AC135721
  115. NM_001407737.1NP_001394666.1  breast cancer type 1 susceptibility protein isoform 36

    Status: REVIEWED

    Source sequence(s)
    AC135721
  116. NM_001407738.1NP_001394667.1  breast cancer type 1 susceptibility protein isoform 36

    Status: REVIEWED

    Source sequence(s)
    AC135721
  117. NM_001407739.1NP_001394668.1  breast cancer type 1 susceptibility protein isoform 36

    Status: REVIEWED

    Source sequence(s)
    AC135721
  118. NM_001407740.1NP_001394669.1  breast cancer type 1 susceptibility protein isoform 37

    Status: REVIEWED

    Source sequence(s)
    AC135721
  119. NM_001407741.1NP_001394670.1  breast cancer type 1 susceptibility protein isoform 37

    Status: REVIEWED

    Source sequence(s)
    AC135721
  120. NM_001407742.1NP_001394671.1  breast cancer type 1 susceptibility protein isoform 37

    Status: REVIEWED

    Source sequence(s)
    AC135721
  121. NM_001407743.1NP_001394672.1  breast cancer type 1 susceptibility protein isoform 37

    Status: REVIEWED

    Source sequence(s)
    AC135721
  122. NM_001407744.1NP_001394673.1  breast cancer type 1 susceptibility protein isoform 37

    Status: REVIEWED

    Source sequence(s)
    AC135721
  123. NM_001407745.1NP_001394674.1  breast cancer type 1 susceptibility protein isoform 37

    Status: REVIEWED

    Source sequence(s)
    AC135721
  124. NM_001407746.1NP_001394675.1  breast cancer type 1 susceptibility protein isoform 37

    Status: REVIEWED

    Source sequence(s)
    AC135721
  125. NM_001407747.1NP_001394676.1  breast cancer type 1 susceptibility protein isoform 37

    Status: REVIEWED

    Source sequence(s)
    AC135721
  126. NM_001407748.1NP_001394677.1  breast cancer type 1 susceptibility protein isoform 37

    Status: REVIEWED

    Source sequence(s)
    AC135721
  127. NM_001407749.1NP_001394678.1  breast cancer type 1 susceptibility protein isoform 37

    Status: REVIEWED

    Source sequence(s)
    AC135721
  128. NM_001407750.1NP_001394679.1  breast cancer type 1 susceptibility protein isoform 38

    Status: REVIEWED

    Source sequence(s)
    AC135721
  129. NM_001407751.1NP_001394680.1  breast cancer type 1 susceptibility protein isoform 38

    Status: REVIEWED

    Source sequence(s)
    AC135721
  130. NM_001407752.1NP_001394681.1  breast cancer type 1 susceptibility protein isoform 38

    Status: REVIEWED

    Source sequence(s)
    AC135721
  131. NM_001407838.1NP_001394767.1  breast cancer type 1 susceptibility protein isoform 39

    Status: REVIEWED

    Source sequence(s)
    AC135721
  132. NM_001407839.1NP_001394768.1  breast cancer type 1 susceptibility protein isoform 39

    Status: REVIEWED

    Source sequence(s)
    AC135721
  133. NM_001407841.1NP_001394770.1  breast cancer type 1 susceptibility protein isoform 39

    Status: REVIEWED

    Source sequence(s)
    AC135721
  134. NM_001407842.1NP_001394771.1  breast cancer type 1 susceptibility protein isoform 39

    Status: REVIEWED

    Source sequence(s)
    AC135721
  135. NM_001407843.1NP_001394772.1  breast cancer type 1 susceptibility protein isoform 39

    Status: REVIEWED

    Source sequence(s)
    AC135721
  136. NM_001407844.1NP_001394773.1  breast cancer type 1 susceptibility protein isoform 39

    Status: REVIEWED

    Source sequence(s)
    AC135721
  137. NM_001407845.1NP_001394774.1  breast cancer type 1 susceptibility protein isoform 39

    Status: REVIEWED

    Source sequence(s)
    AC135721
  138. NM_001407846.1NP_001394775.1  breast cancer type 1 susceptibility protein isoform 39

    Status: REVIEWED

    Source sequence(s)
    AC135721
  139. NM_001407847.1NP_001394776.1  breast cancer type 1 susceptibility protein isoform 40

    Status: REVIEWED

    Source sequence(s)
    AC135721
  140. NM_001407848.1NP_001394777.1  breast cancer type 1 susceptibility protein isoform 40

    Status: REVIEWED

    Source sequence(s)
    AC135721
  141. NM_001407849.1NP_001394778.1  breast cancer type 1 susceptibility protein isoform 40

    Status: REVIEWED

    Source sequence(s)
    AC135721
  142. NM_001407850.1NP_001394779.1  breast cancer type 1 susceptibility protein isoform 41

    Status: REVIEWED

    Source sequence(s)
    AC135721
  143. NM_001407851.1NP_001394780.1  breast cancer type 1 susceptibility protein isoform 41

    Status: REVIEWED

    Source sequence(s)
    AC135721
  144. NM_001407852.1NP_001394781.1  breast cancer type 1 susceptibility protein isoform 41

    Status: REVIEWED

    Source sequence(s)
    AC135721
  145. NM_001407853.1NP_001394782.1  breast cancer type 1 susceptibility protein isoform 42

    Status: REVIEWED

    Source sequence(s)
    AC135721
  146. NM_001407854.1NP_001394783.1  breast cancer type 1 susceptibility protein isoform 43

    Status: REVIEWED

    Source sequence(s)
    AC135721
  147. NM_001407858.1NP_001394787.1  breast cancer type 1 susceptibility protein isoform 44

    Status: REVIEWED

    Source sequence(s)
    AC135721
  148. NM_001407859.1NP_001394788.1  breast cancer type 1 susceptibility protein isoform 44

    Status: REVIEWED

    Source sequence(s)
    AC135721
  149. NM_001407860.1NP_001394789.1  breast cancer type 1 susceptibility protein isoform 45

    Status: REVIEWED

    Source sequence(s)
    AC135721
  150. NM_001407861.1NP_001394790.1  breast cancer type 1 susceptibility protein isoform 46

    Status: REVIEWED

    Source sequence(s)
    AC135721
  151. NM_001407862.1NP_001394791.1  breast cancer type 1 susceptibility protein isoform 47

    Status: REVIEWED

    Source sequence(s)
    AC135721
  152. NM_001407863.1NP_001394792.1  breast cancer type 1 susceptibility protein isoform 48

    Status: REVIEWED

    Source sequence(s)
    AC135721
  153. NM_001407874.1NP_001394803.1  breast cancer type 1 susceptibility protein isoform 49

    Status: REVIEWED

    Source sequence(s)
    AC135721
  154. NM_001407875.1NP_001394804.1  breast cancer type 1 susceptibility protein isoform 49

    Status: REVIEWED

    Source sequence(s)
    AC135721
  155. NM_001407879.1NP_001394808.1  breast cancer type 1 susceptibility protein isoform 50

    Status: REVIEWED

    Source sequence(s)
    AC135721
  156. NM_001407881.1NP_001394810.1  breast cancer type 1 susceptibility protein isoform 50

    Status: REVIEWED

    Source sequence(s)
    AC135721
  157. NM_001407882.1NP_001394811.1  breast cancer type 1 susceptibility protein isoform 50

    Status: REVIEWED

    Source sequence(s)
    AC135721
  158. NM_001407884.1NP_001394813.1  breast cancer type 1 susceptibility protein isoform 50

    Status: REVIEWED

    Source sequence(s)
    AC135721
  159. NM_001407885.1NP_001394814.1  breast cancer type 1 susceptibility protein isoform 50

    Status: REVIEWED

    Source sequence(s)
    AC135721
  160. NM_001407886.1NP_001394815.1  breast cancer type 1 susceptibility protein isoform 50

    Status: REVIEWED

    Source sequence(s)
    AC135721
  161. NM_001407887.1NP_001394816.1  breast cancer type 1 susceptibility protein isoform 50

    Status: REVIEWED

    Source sequence(s)
    AC135721
  162. NM_001407889.1NP_001394818.1  breast cancer type 1 susceptibility protein isoform 50

    Status: REVIEWED

    Source sequence(s)
    AC135721
  163. NM_001407894.1NP_001394823.1  breast cancer type 1 susceptibility protein isoform 51

    Status: REVIEWED

    Source sequence(s)
    AC135721
  164. NM_001407895.1NP_001394824.1  breast cancer type 1 susceptibility protein isoform 51

    Status: REVIEWED

    Source sequence(s)
    AC135721
  165. NM_001407896.1NP_001394825.1  breast cancer type 1 susceptibility protein isoform 51

    Status: REVIEWED

    Source sequence(s)
    AC135721
  166. NM_001407897.1NP_001394826.1  breast cancer type 1 susceptibility protein isoform 51

    Status: REVIEWED

    Source sequence(s)
    AC135721
  167. NM_001407898.1NP_001394827.1  breast cancer type 1 susceptibility protein isoform 51

    Status: REVIEWED

    Source sequence(s)
    AC135721
  168. NM_001407899.1NP_001394828.1  breast cancer type 1 susceptibility protein isoform 51

    Status: REVIEWED

    Source sequence(s)
    AC135721
  169. NM_001407900.1NP_001394829.1  breast cancer type 1 susceptibility protein isoform 52

    Status: REVIEWED

    Source sequence(s)
    AC135721
  170. NM_001407902.1NP_001394831.1  breast cancer type 1 susceptibility protein isoform 52

    Status: REVIEWED

    Source sequence(s)
    AC135721
  171. NM_001407904.1NP_001394833.1  breast cancer type 1 susceptibility protein isoform 52

    Status: REVIEWED

    Source sequence(s)
    AC135721
  172. NM_001407906.1NP_001394835.1  breast cancer type 1 susceptibility protein isoform 52

    Status: REVIEWED

    Source sequence(s)
    AC135721
  173. NM_001407907.1NP_001394836.1  breast cancer type 1 susceptibility protein isoform 53

    Status: REVIEWED

    Source sequence(s)
    AC135721
  174. NM_001407908.1NP_001394837.1  breast cancer type 1 susceptibility protein isoform 53

    Status: REVIEWED

    Source sequence(s)
    AC135721
  175. NM_001407909.1NP_001394838.1  breast cancer type 1 susceptibility protein isoform 53

    Status: REVIEWED

    Source sequence(s)
    AC135721
  176. NM_001407910.1NP_001394839.1  breast cancer type 1 susceptibility protein isoform 53

    Status: REVIEWED

    Source sequence(s)
    AC135721
  177. NM_001407915.1NP_001394844.1  breast cancer type 1 susceptibility protein isoform 54

    Status: REVIEWED

    Source sequence(s)
    AC135721
  178. NM_001407916.1NP_001394845.1  breast cancer type 1 susceptibility protein isoform 55

    Status: REVIEWED

    Source sequence(s)
    AC135721
  179. NM_001407917.1NP_001394846.1  breast cancer type 1 susceptibility protein isoform 55

    Status: REVIEWED

    Source sequence(s)
    AC135721
  180. NM_001407918.1NP_001394847.1  breast cancer type 1 susceptibility protein isoform 55

    Status: REVIEWED

    Source sequence(s)
    AC135721
  181. NM_001407919.1NP_001394848.1  breast cancer type 1 susceptibility protein isoform 56

    Status: REVIEWED

    Source sequence(s)
    AC135721
  182. NM_001407920.1NP_001394849.1  breast cancer type 1 susceptibility protein isoform 57

    Status: REVIEWED

    Source sequence(s)
    AC135721
  183. NM_001407921.1NP_001394850.1  breast cancer type 1 susceptibility protein isoform 57

    Status: REVIEWED

    Source sequence(s)
    AC135721
  184. NM_001407922.1NP_001394851.1  breast cancer type 1 susceptibility protein isoform 57

    Status: REVIEWED

    Source sequence(s)
    AC135721
  185. NM_001407923.1NP_001394852.1  breast cancer type 1 susceptibility protein isoform 57

    Status: REVIEWED

    Source sequence(s)
    AC135721
  186. NM_001407924.1NP_001394853.1  breast cancer type 1 susceptibility protein isoform 57

    Status: REVIEWED

    Source sequence(s)
    AC135721
  187. NM_001407925.1NP_001394854.1  breast cancer type 1 susceptibility protein isoform 57

    Status: REVIEWED

    Source sequence(s)
    AC135721
  188. NM_001407926.1NP_001394855.1  breast cancer type 1 susceptibility protein isoform 57

    Status: REVIEWED

    Source sequence(s)
    AC135721
  189. NM_001407927.1NP_001394856.1  breast cancer type 1 susceptibility protein isoform 58

    Status: REVIEWED

    Source sequence(s)
    AC135721
  190. NM_001407928.1NP_001394857.1  breast cancer type 1 susceptibility protein isoform 58

    Status: REVIEWED

    Source sequence(s)
    AC135721
  191. NM_001407929.1NP_001394858.1  breast cancer type 1 susceptibility protein isoform 58

    Status: REVIEWED

    Source sequence(s)
    AC135721
  192. NM_001407930.1NP_001394859.1  breast cancer type 1 susceptibility protein isoform 59

    Status: REVIEWED

    Source sequence(s)
    AC135721
  193. NM_001407931.1NP_001394860.1  breast cancer type 1 susceptibility protein isoform 59

    Status: REVIEWED

    Source sequence(s)
    AC135721
  194. NM_001407932.1NP_001394861.1  breast cancer type 1 susceptibility protein isoform 59

    Status: REVIEWED

    Source sequence(s)
    AC135721
  195. NM_001407933.1NP_001394862.1  breast cancer type 1 susceptibility protein isoform 60

    Status: REVIEWED

    Source sequence(s)
    AC135721
  196. NM_001407934.1NP_001394863.1  breast cancer type 1 susceptibility protein isoform 61

    Status: REVIEWED

    Source sequence(s)
    AC135721
  197. NM_001407935.1NP_001394864.1  breast cancer type 1 susceptibility protein isoform 62

    Status: REVIEWED

    Source sequence(s)
    AC135721
  198. NM_001407936.1NP_001394865.1  breast cancer type 1 susceptibility protein isoform 63

    Status: REVIEWED

    Source sequence(s)
    AC135721
  199. NM_001407937.1NP_001394866.1  breast cancer type 1 susceptibility protein isoform 64

    Status: REVIEWED

    Source sequence(s)
    AC135721
  200. NM_001407938.1NP_001394867.1  breast cancer type 1 susceptibility protein isoform 64

    Status: REVIEWED

    Source sequence(s)
    AC135721
  201. NM_001407939.1NP_001394868.1  breast cancer type 1 susceptibility protein isoform 65

    Status: REVIEWED

    Source sequence(s)
    AC135721
  202. NM_001407940.1NP_001394869.1  breast cancer type 1 susceptibility protein isoform 66

    Status: REVIEWED

    Source sequence(s)
    AC135721
  203. NM_001407941.1NP_001394870.1  breast cancer type 1 susceptibility protein isoform 67

    Status: REVIEWED

    Source sequence(s)
    AC135721
  204. NM_001407942.1NP_001394871.1  breast cancer type 1 susceptibility protein isoform 68

    Status: REVIEWED

    Source sequence(s)
    AC135721
  205. NM_001407943.1NP_001394872.1  breast cancer type 1 susceptibility protein isoform 69

    Status: REVIEWED

    Source sequence(s)
    AC135721
  206. NM_001407944.1NP_001394873.1  breast cancer type 1 susceptibility protein isoform 70

    Status: REVIEWED

    Source sequence(s)
    AC135721
  207. NM_001407945.1NP_001394874.1  breast cancer type 1 susceptibility protein isoform 70

    Status: REVIEWED

    Source sequence(s)
    AC135721
  208. NM_001407946.1NP_001394875.1  breast cancer type 1 susceptibility protein isoform 71

    Status: REVIEWED

    Source sequence(s)
    AC135721
  209. NM_001407947.1NP_001394876.1  breast cancer type 1 susceptibility protein isoform 71

    Status: REVIEWED

    Source sequence(s)
    AC135721
  210. NM_001407948.1NP_001394877.1  breast cancer type 1 susceptibility protein isoform 71

    Status: REVIEWED

    Source sequence(s)
    AC135721
  211. NM_001407949.1NP_001394878.1  breast cancer type 1 susceptibility protein isoform 71

    Status: REVIEWED

    Source sequence(s)
    AC135721
  212. NM_001407950.1NP_001394879.1  breast cancer type 1 susceptibility protein isoform 72

    Status: REVIEWED

    Source sequence(s)
    AC135721
  213. NM_001407951.1NP_001394880.1  breast cancer type 1 susceptibility protein isoform 72

    Status: REVIEWED

    Source sequence(s)
    AC135721
  214. NM_001407952.1NP_001394881.1  breast cancer type 1 susceptibility protein isoform 73

    Status: REVIEWED

    Source sequence(s)
    AC135721
  215. NM_001407953.1NP_001394882.1  breast cancer type 1 susceptibility protein isoform 73

    Status: REVIEWED

    Source sequence(s)
    AC135721
  216. NM_001407954.1NP_001394883.1  breast cancer type 1 susceptibility protein isoform 74

    Status: REVIEWED

    Source sequence(s)
    AC135721
  217. NM_001407955.1NP_001394884.1  breast cancer type 1 susceptibility protein isoform 74

    Status: REVIEWED

    Source sequence(s)
    AC135721
  218. NM_001407956.1NP_001394885.1  breast cancer type 1 susceptibility protein isoform 75

    Status: REVIEWED

    Source sequence(s)
    AC135721
  219. NM_001407957.1NP_001394886.1  breast cancer type 1 susceptibility protein isoform 76

    Status: REVIEWED

    Source sequence(s)
    AC135721
  220. NM_001407958.1NP_001394887.1  breast cancer type 1 susceptibility protein isoform 77

    Status: REVIEWED

    Source sequence(s)
    AC135721
  221. NM_001407959.1NP_001394888.1  breast cancer type 1 susceptibility protein isoform 78

    Status: REVIEWED

    Source sequence(s)
    AC135721
  222. NM_001407960.1NP_001394889.1  breast cancer type 1 susceptibility protein isoform 79

    Status: REVIEWED

    Source sequence(s)
    AC135721
  223. NM_001407962.1NP_001394891.1  breast cancer type 1 susceptibility protein isoform 80

    Status: REVIEWED

    Source sequence(s)
    AC135721
  224. NM_001407963.1NP_001394892.1  breast cancer type 1 susceptibility protein isoform 81

    Status: REVIEWED

    Source sequence(s)
    AC135721
  225. NM_001407964.1NP_001394893.1  breast cancer type 1 susceptibility protein isoform 82

    Status: REVIEWED

    Source sequence(s)
    AC135721
  226. NM_001407965.1NP_001394894.1  breast cancer type 1 susceptibility protein isoform 83

    Status: REVIEWED

    Source sequence(s)
    AC135721
  227. NM_001407966.1NP_001394895.1  breast cancer type 1 susceptibility protein isoform 84

    Status: REVIEWED

    Source sequence(s)
    AC135721
  228. NM_001407967.1NP_001394896.1  breast cancer type 1 susceptibility protein isoform 85

    Status: REVIEWED

    Source sequence(s)
    AC135721
  229. NM_001407968.1NP_001394897.1  breast cancer type 1 susceptibility protein isoform 86

    Status: REVIEWED

    Source sequence(s)
    AC135721
  230. NM_001407969.1NP_001394898.1  breast cancer type 1 susceptibility protein isoform 87

    Status: REVIEWED

    Source sequence(s)
    AC135721
  231. NM_001407970.1NP_001394899.1  breast cancer type 1 susceptibility protein isoform 88

    Status: REVIEWED

    Source sequence(s)
    AC135721
  232. NM_001407971.1NP_001394900.1  breast cancer type 1 susceptibility protein isoform 88

    Status: REVIEWED

    Source sequence(s)
    AC135721
  233. NM_001407972.1NP_001394901.1  breast cancer type 1 susceptibility protein isoform 89

    Status: REVIEWED

    Source sequence(s)
    AC135721
  234. NM_001407973.1NP_001394902.1  breast cancer type 1 susceptibility protein isoform 90

    Status: REVIEWED

    Source sequence(s)
    AC135721
  235. NM_001407974.1NP_001394903.1  breast cancer type 1 susceptibility protein isoform 90

    Status: REVIEWED

    Source sequence(s)
    AC135721
  236. NM_001407975.1NP_001394904.1  breast cancer type 1 susceptibility protein isoform 90

    Status: REVIEWED

    Source sequence(s)
    AC135721
  237. NM_001407976.1NP_001394905.1  breast cancer type 1 susceptibility protein isoform 90

    Status: REVIEWED

    Source sequence(s)
    AC135721
  238. NM_001407977.1NP_001394906.1  breast cancer type 1 susceptibility protein isoform 90

    Status: REVIEWED

    Source sequence(s)
    AC135721
  239. NM_001407978.1NP_001394907.1  breast cancer type 1 susceptibility protein isoform 90

    Status: REVIEWED

    Source sequence(s)
    AC135721
  240. NM_001407979.1NP_001394908.1  breast cancer type 1 susceptibility protein isoform 91

    Status: REVIEWED

    Source sequence(s)
    AC135721
  241. NM_001407980.1NP_001394909.1  breast cancer type 1 susceptibility protein isoform 91

    Status: REVIEWED

    Source sequence(s)
    AC135721
  242. NM_001407981.1NP_001394910.1  breast cancer type 1 susceptibility protein isoform 91

    Status: REVIEWED

    Source sequence(s)
    AC135721
  243. NM_001407982.1NP_001394911.1  breast cancer type 1 susceptibility protein isoform 91

    Status: REVIEWED

    Source sequence(s)
    AC135721
  244. NM_001407983.1NP_001394912.1  breast cancer type 1 susceptibility protein isoform 91

    Status: REVIEWED

    Source sequence(s)
    AC135721
  245. NM_001407984.1NP_001394913.1  breast cancer type 1 susceptibility protein isoform 92

    Status: REVIEWED

    Source sequence(s)
    AC135721
  246. NM_001407985.1NP_001394914.1  breast cancer type 1 susceptibility protein isoform 92

    Status: REVIEWED

    Source sequence(s)
    AC135721
  247. NM_001407986.1NP_001394915.1  breast cancer type 1 susceptibility protein isoform 92

    Status: REVIEWED

    Source sequence(s)
    AC135721
  248. NM_001407990.1NP_001394919.1  breast cancer type 1 susceptibility protein isoform 91

    Status: REVIEWED

    Source sequence(s)
    AC135721
  249. NM_001407991.1NP_001394920.1  breast cancer type 1 susceptibility protein isoform 92

    Status: REVIEWED

    Source sequence(s)
    AC135721
  250. NM_001407992.1NP_001394921.1  breast cancer type 1 susceptibility protein isoform 92

    Status: REVIEWED

    Source sequence(s)
    AC135721
  251. NM_001407993.1NP_001394922.1  breast cancer type 1 susceptibility protein isoform 4

    Status: REVIEWED

    Source sequence(s)
    AC135721
    UniProtKB/TrEMBL
    A0A024R1V0
  252. NM_001408392.1NP_001395321.1  breast cancer type 1 susceptibility protein isoform 94

    Status: REVIEWED

    Source sequence(s)
    AC135721
  253. NM_001408396.1NP_001395325.1  breast cancer type 1 susceptibility protein isoform 94

    Status: REVIEWED

    Source sequence(s)
    AC135721
  254. NM_001408397.1NP_001395326.1  breast cancer type 1 susceptibility protein isoform 94

    Status: REVIEWED

    Source sequence(s)
    AC135721
  255. NM_001408398.1NP_001395327.1  breast cancer type 1 susceptibility protein isoform 94

    Status: REVIEWED

    Source sequence(s)
    AC135721
  256. NM_001408399.1NP_001395328.1  breast cancer type 1 susceptibility protein isoform 94

    Status: REVIEWED

    Source sequence(s)
    AC135721
  257. NM_001408400.1NP_001395329.1  breast cancer type 1 susceptibility protein isoform 95

    Status: REVIEWED

    Source sequence(s)
    AC135721
  258. NM_001408401.1NP_001395330.1  breast cancer type 1 susceptibility protein isoform 95

    Status: REVIEWED

    Source sequence(s)
    AC135721
  259. NM_001408402.1NP_001395331.1  breast cancer type 1 susceptibility protein isoform 95

    Status: REVIEWED

    Source sequence(s)
    AC135721
  260. NM_001408403.1NP_001395332.1  breast cancer type 1 susceptibility protein isoform 96

    Status: REVIEWED

    Source sequence(s)
    AC135721
  261. NM_001408404.1NP_001395333.1  breast cancer type 1 susceptibility protein isoform 96

    Status: REVIEWED

    Source sequence(s)
    AC135721
  262. NM_001408406.1NP_001395335.1  breast cancer type 1 susceptibility protein isoform 97

    Status: REVIEWED

    Source sequence(s)
    AC135721
  263. NM_001408407.1NP_001395336.1  breast cancer type 1 susceptibility protein isoform 98

    Status: REVIEWED

    Source sequence(s)
    AC135721
  264. NM_001408408.1NP_001395337.1  breast cancer type 1 susceptibility protein isoform 99

    Status: REVIEWED

    Source sequence(s)
    AC135721
  265. NM_001408409.1NP_001395338.1  breast cancer type 1 susceptibility protein isoform 100

    Status: REVIEWED

    Source sequence(s)
    AC135721
  266. NM_001408410.1NP_001395339.1  breast cancer type 1 susceptibility protein isoform 101

    Status: REVIEWED

    Source sequence(s)
    AC135721
  267. NM_001408411.1NP_001395340.1  breast cancer type 1 susceptibility protein isoform 102

    Status: REVIEWED

    Source sequence(s)
    AC135721
  268. NM_001408412.1NP_001395341.1  breast cancer type 1 susceptibility protein isoform 103

    Status: REVIEWED

    Source sequence(s)
    AC135721
  269. NM_001408413.1NP_001395342.1  breast cancer type 1 susceptibility protein isoform 104

    Status: REVIEWED

    Source sequence(s)
    AC135721
  270. NM_001408414.1NP_001395343.1  breast cancer type 1 susceptibility protein isoform 103

    Status: REVIEWED

    Source sequence(s)
    AC135721
  271. NM_001408415.1NP_001395344.1  breast cancer type 1 susceptibility protein isoform 103

    Status: REVIEWED

    Source sequence(s)
    AC135721
  272. NM_001408416.1NP_001395345.1  breast cancer type 1 susceptibility protein isoform 104

    Status: REVIEWED

    Source sequence(s)
    AC135721
  273. NM_001408418.1NP_001395347.1  breast cancer type 1 susceptibility protein isoform 105

    Status: REVIEWED

    Source sequence(s)
    AC135721
    UniProtKB/TrEMBL
    A0A024R1Z8
  274. NM_001408419.1NP_001395348.1  breast cancer type 1 susceptibility protein isoform 105

    Status: REVIEWED

    Source sequence(s)
    AC135721
    UniProtKB/TrEMBL
    A0A024R1Z8
  275. NM_001408420.1NP_001395349.1  breast cancer type 1 susceptibility protein isoform 105

    Status: REVIEWED

    Source sequence(s)
    AC135721
    UniProtKB/TrEMBL
    A0A024R1Z8
  276. NM_001408421.1NP_001395350.1  breast cancer type 1 susceptibility protein isoform 106

    Status: REVIEWED

    Source sequence(s)
    AC135721
  277. NM_001408422.1NP_001395351.1  breast cancer type 1 susceptibility protein isoform 107

    Status: REVIEWED

    Source sequence(s)
    AC135721
  278. NM_001408423.1NP_001395352.1  breast cancer type 1 susceptibility protein isoform 107

    Status: REVIEWED

    Source sequence(s)
    AC135721
  279. NM_001408424.1NP_001395353.1  breast cancer type 1 susceptibility protein isoform 106

    Status: REVIEWED

    Source sequence(s)
    AC135721
  280. NM_001408425.1NP_001395354.1  breast cancer type 1 susceptibility protein isoform 108

    Status: REVIEWED

    Source sequence(s)
    AC135721
    UniProtKB/TrEMBL
    A0A024R1V7
  281. NM_001408426.1NP_001395355.1  breast cancer type 1 susceptibility protein isoform 108

    Status: REVIEWED

    Source sequence(s)
    AC135721
    UniProtKB/TrEMBL
    A0A024R1V7
  282. NM_001408427.1NP_001395356.1  breast cancer type 1 susceptibility protein isoform 108

    Status: REVIEWED

    Source sequence(s)
    AC135721
    UniProtKB/TrEMBL
    A0A024R1V7
  283. NM_001408428.1NP_001395357.1  breast cancer type 1 susceptibility protein isoform 108

    Status: REVIEWED

    Source sequence(s)
    AC135721
    UniProtKB/TrEMBL
    A0A024R1V7
  284. NM_001408429.1NP_001395358.1  breast cancer type 1 susceptibility protein isoform 108

    Status: REVIEWED

    Source sequence(s)
    AC135721
    UniProtKB/TrEMBL
    A0A024R1V7
  285. NM_001408430.1NP_001395359.1  breast cancer type 1 susceptibility protein isoform 108

    Status: REVIEWED

    Source sequence(s)
    AC135721
    UniProtKB/TrEMBL
    A0A024R1V7
  286. NM_001408431.1NP_001395360.1  breast cancer type 1 susceptibility protein isoform 109

    Status: REVIEWED

    Source sequence(s)
    AC135721
  287. NM_001408432.1NP_001395361.1  breast cancer type 1 susceptibility protein isoform 110

    Status: REVIEWED

    Source sequence(s)
    AC135721
  288. NM_001408433.1NP_001395362.1  breast cancer type 1 susceptibility protein isoform 110

    Status: REVIEWED

    Source sequence(s)
    AC135721
  289. NM_001408434.1NP_001395363.1  breast cancer type 1 susceptibility protein isoform 110

    Status: REVIEWED

    Source sequence(s)
    AC135721
  290. NM_001408435.1NP_001395364.1  breast cancer type 1 susceptibility protein isoform 110

    Status: REVIEWED

    Source sequence(s)
    AC135721
  291. NM_001408436.1NP_001395365.1  breast cancer type 1 susceptibility protein isoform 111

    Status: REVIEWED

    Source sequence(s)
    AC135721
  292. NM_001408437.1NP_001395366.1  breast cancer type 1 susceptibility protein isoform 111

    Status: REVIEWED

    Source sequence(s)
    AC135721
  293. NM_001408438.1NP_001395367.1  breast cancer type 1 susceptibility protein isoform 111

    Status: REVIEWED

    Source sequence(s)
    AC135721
  294. NM_001408439.1NP_001395368.1  breast cancer type 1 susceptibility protein isoform 111

    Status: REVIEWED

    Source sequence(s)
    AC135721
  295. NM_001408440.1NP_001395369.1  breast cancer type 1 susceptibility protein isoform 111

    Status: REVIEWED

    Source sequence(s)
    AC135721
  296. NM_001408441.1NP_001395370.1  breast cancer type 1 susceptibility protein isoform 112

    Status: REVIEWED

    Source sequence(s)
    AC135721
  297. NM_001408442.1NP_001395371.1  breast cancer type 1 susceptibility protein isoform 112

    Status: REVIEWED

    Source sequence(s)
    AC135721
  298. NM_001408443.1NP_001395372.1  breast cancer type 1 susceptibility protein isoform 112

    Status: REVIEWED

    Source sequence(s)
    AC135721
  299. NM_001408444.1NP_001395373.1  breast cancer type 1 susceptibility protein isoform 112

    Status: REVIEWED

    Source sequence(s)
    AC135721
  300. NM_001408445.1NP_001395374.1  breast cancer type 1 susceptibility protein isoform 113

    Status: REVIEWED

    Source sequence(s)
    AC135721
  301. NM_001408446.1NP_001395375.1  breast cancer type 1 susceptibility protein isoform 113

    Status: REVIEWED

    Source sequence(s)
    AC135721
  302. NM_001408447.1NP_001395376.1  breast cancer type 1 susceptibility protein isoform 113

    Status: REVIEWED

    Source sequence(s)
    AC135721
  303. NM_001408448.1NP_001395377.1  breast cancer type 1 susceptibility protein isoform 113

    Status: REVIEWED

    Source sequence(s)
    AC135721
  304. NM_001408450.1NP_001395379.1  breast cancer type 1 susceptibility protein isoform 113

    Status: REVIEWED

    Source sequence(s)
    AC135721
  305. NM_001408451.1NP_001395380.1  breast cancer type 1 susceptibility protein isoform 114

    Status: REVIEWED

    Source sequence(s)
    AC135721
  306. NM_001408452.1NP_001395381.1  breast cancer type 1 susceptibility protein isoform 115

    Status: REVIEWED

    Source sequence(s)
    AC135721
  307. NM_001408453.1NP_001395382.1  breast cancer type 1 susceptibility protein isoform 115

    Status: REVIEWED

    Source sequence(s)
    AC135721
  308. NM_001408454.1NP_001395383.1  breast cancer type 1 susceptibility protein isoform 115

    Status: REVIEWED

    Source sequence(s)
    AC135721
  309. NM_001408455.1NP_001395384.1  breast cancer type 1 susceptibility protein isoform 115

    Status: REVIEWED

    Source sequence(s)
    AC135721
  310. NM_001408456.1NP_001395385.1  breast cancer type 1 susceptibility protein isoform 115

    Status: REVIEWED

    Source sequence(s)
    AC135721
  311. NM_001408457.1NP_001395386.1  breast cancer type 1 susceptibility protein isoform 115

    Status: REVIEWED

    Source sequence(s)
    AC135721
  312. NM_001408458.1NP_001395387.1  breast cancer type 1 susceptibility protein isoform 116

    Status: REVIEWED

    Source sequence(s)
    AC060780, AC135721
    UniProtKB/TrEMBL
    B4DES0
  313. NM_001408459.1NP_001395388.1  breast cancer type 1 susceptibility protein isoform 116

    Status: REVIEWED

    Source sequence(s)
    AC135721
    UniProtKB/TrEMBL
    B4DES0
  314. NM_001408460.1NP_001395389.1  breast cancer type 1 susceptibility protein isoform 116

    Status: REVIEWED

    Source sequence(s)
    AC135721
    UniProtKB/TrEMBL
    B4DES0
  315. NM_001408461.1NP_001395390.1  breast cancer type 1 susceptibility protein isoform 116

    Status: REVIEWED

    Source sequence(s)
    AC135721
    UniProtKB/TrEMBL
    B4DES0
  316. NM_001408462.1NP_001395391.1  breast cancer type 1 susceptibility protein isoform 117

    Status: REVIEWED

    Source sequence(s)
    AC135721
  317. NM_001408463.1NP_001395392.1  breast cancer type 1 susceptibility protein isoform 117

    Status: REVIEWED

    Source sequence(s)
    AC135721
  318. NM_001408464.1NP_001395393.1  breast cancer type 1 susceptibility protein isoform 117

    Status: REVIEWED

    Source sequence(s)
    AC135721
  319. NM_001408465.1NP_001395394.1  breast cancer type 1 susceptibility protein isoform 117

    Status: REVIEWED

    Source sequence(s)
    AC135721
  320. NM_001408466.1NP_001395395.1  breast cancer type 1 susceptibility protein isoform 118

    Status: REVIEWED

    Source sequence(s)
    AC135721
  321. NM_001408467.1NP_001395396.1  breast cancer type 1 susceptibility protein isoform 118

    Status: REVIEWED

    Source sequence(s)
    AC135721
  322. NM_001408468.1NP_001395397.1  breast cancer type 1 susceptibility protein isoform 119

    Status: REVIEWED

    Source sequence(s)
    AC135721
  323. NM_001408469.1NP_001395398.1  breast cancer type 1 susceptibility protein isoform 120

    Status: REVIEWED

    Source sequence(s)
    AC135721
  324. NM_001408470.1NP_001395399.1  breast cancer type 1 susceptibility protein isoform 121

    Status: REVIEWED

    Source sequence(s)
    AC135721
  325. NM_001408472.1NP_001395401.1  breast cancer type 1 susceptibility protein isoform 122

    Status: REVIEWED

    Source sequence(s)
    AC135721
  326. NM_001408473.1NP_001395402.1  breast cancer type 1 susceptibility protein isoform 123

    Status: REVIEWED

    Source sequence(s)
    AC135721
  327. NM_001408474.1NP_001395403.1  breast cancer type 1 susceptibility protein isoform 124

    Status: REVIEWED

    Source sequence(s)
    AC135721
  328. NM_001408475.1NP_001395404.1  breast cancer type 1 susceptibility protein isoform 125

    Status: REVIEWED

    Source sequence(s)
    AC135721
  329. NM_001408476.1NP_001395405.1  breast cancer type 1 susceptibility protein isoform 126

    Status: REVIEWED

    Source sequence(s)
    AC135721
  330. NM_001408478.1NP_001395407.1  breast cancer type 1 susceptibility protein isoform 127

    Status: REVIEWED

    Source sequence(s)
    AC135721
  331. NM_001408479.1NP_001395408.1  breast cancer type 1 susceptibility protein isoform 127

    Status: REVIEWED

    Source sequence(s)
    AC135721
  332. NM_001408480.1NP_001395409.1  breast cancer type 1 susceptibility protein isoform 127

    Status: REVIEWED

    Source sequence(s)
    AC135721
  333. NM_001408481.1NP_001395410.1  breast cancer type 1 susceptibility protein isoform 128

    Status: REVIEWED

    Source sequence(s)
    AC135721
  334. NM_001408482.1NP_001395411.1  breast cancer type 1 susceptibility protein isoform 128

    Status: REVIEWED

    Source sequence(s)
    AC135721
  335. NM_001408483.1NP_001395412.1  breast cancer type 1 susceptibility protein isoform 128

    Status: REVIEWED

    Source sequence(s)
    AC135721
  336. NM_001408484.1NP_001395413.1  breast cancer type 1 susceptibility protein isoform 128

    Status: REVIEWED

    Source sequence(s)
    AC135721
  337. NM_001408485.1NP_001395414.1  breast cancer type 1 susceptibility protein isoform 128

    Status: REVIEWED

    Source sequence(s)
    AC135721
  338. NM_001408489.1NP_001395418.1  breast cancer type 1 susceptibility protein isoform 129

    Status: REVIEWED

    Source sequence(s)
    AC135721
  339. NM_001408490.1NP_001395419.1  breast cancer type 1 susceptibility protein isoform 130

    Status: REVIEWED

    Source sequence(s)
    AC135721
  340. NM_001408491.1NP_001395420.1  breast cancer type 1 susceptibility protein isoform 130

    Status: REVIEWED

    Source sequence(s)
    AC135721
  341. NM_001408492.1NP_001395421.1  breast cancer type 1 susceptibility protein isoform 131

    Status: REVIEWED

    Source sequence(s)
    AC135721
  342. NM_001408493.1NP_001395422.1  breast cancer type 1 susceptibility protein isoform 132

    Status: REVIEWED

    Source sequence(s)
    AC135721
  343. NM_001408494.1NP_001395423.1  breast cancer type 1 susceptibility protein isoform 133

    Status: REVIEWED

    Source sequence(s)
    AC135721
    UniProtKB/TrEMBL
    G3XAC3
  344. NM_001408495.1NP_001395424.1  breast cancer type 1 susceptibility protein isoform 134

    Status: REVIEWED

    Source sequence(s)
    AC135721
  345. NM_001408496.1NP_001395425.1  breast cancer type 1 susceptibility protein isoform 135

    Status: REVIEWED

    Source sequence(s)
    AC135721
  346. NM_001408497.1NP_001395426.1  breast cancer type 1 susceptibility protein isoform 135

    Status: REVIEWED

    Source sequence(s)
    AC135721
  347. NM_001408498.1NP_001395427.1  breast cancer type 1 susceptibility protein isoform 135

    Status: REVIEWED

    Source sequence(s)
    AC135721
  348. NM_001408499.1NP_001395428.1  breast cancer type 1 susceptibility protein isoform 135

    Status: REVIEWED

    Source sequence(s)
    AC135721
  349. NM_001408500.1NP_001395429.1  breast cancer type 1 susceptibility protein isoform 135

    Status: REVIEWED

    Source sequence(s)
    AC135721
  350. NM_001408501.1NP_001395430.1  breast cancer type 1 susceptibility protein isoform 135

    Status: REVIEWED

    Source sequence(s)
    AC135721
  351. NM_001408502.1NP_001395431.1  breast cancer type 1 susceptibility protein isoform 136

    Status: REVIEWED

    Source sequence(s)
    AC135721
  352. NM_001408503.1NP_001395432.1  breast cancer type 1 susceptibility protein isoform 137

    Status: REVIEWED

    Source sequence(s)
    AC135721
  353. NM_001408504.1NP_001395433.1  breast cancer type 1 susceptibility protein isoform 137

    Status: REVIEWED

    Source sequence(s)
    AC135721
  354. NM_001408505.1NP_001395434.1  breast cancer type 1 susceptibility protein isoform 138

    Status: REVIEWED

    Source sequence(s)
    AC135721
  355. NM_001408506.1NP_001395435.1  breast cancer type 1 susceptibility protein isoform 139

    Status: REVIEWED

    Source sequence(s)
    AC135721
  356. NM_001408507.1NP_001395436.1  breast cancer type 1 susceptibility protein isoform 140

    Status: REVIEWED

    Source sequence(s)
    AC135721
  357. NM_001408508.1NP_001395437.1  breast cancer type 1 susceptibility protein isoform 141

    Status: REVIEWED

    Source sequence(s)
    AC135721
  358. NM_001408509.1NP_001395438.1  breast cancer type 1 susceptibility protein isoform 142

    Status: REVIEWED

    Source sequence(s)
    AC135721
  359. NM_001408510.1NP_001395439.1  breast cancer type 1 susceptibility protein isoform 143

    Status: REVIEWED

    Source sequence(s)
    AC135721
  360. NM_001408511.1NP_001395440.1  breast cancer type 1 susceptibility protein isoform 144

    Status: REVIEWED

    Source sequence(s)
    AC135721
  361. NM_001408512.1NP_001395441.1  breast cancer type 1 susceptibility protein isoform 145

    Status: REVIEWED

    Source sequence(s)
    AC135721
  362. NM_001408513.1NP_001395442.1  breast cancer type 1 susceptibility protein isoform 146

    Status: REVIEWED

    Source sequence(s)
    AC135721
  363. NM_001408514.1NP_001395443.1  breast cancer type 1 susceptibility protein isoform 147

    Status: REVIEWED

    Source sequence(s)
    AC135721
  364. NM_007294.4NP_009225.1  breast cancer type 1 susceptibility protein isoform 1

    See identical proteins and their annotated locations for NP_009225.1

    Status: REVIEWED

    Source sequence(s)
    AL701927, BC072418, BU617173, BU679389, U14680
    Consensus CDS
    CCDS11453.1
    UniProtKB/Swiss-Prot
    P38398, Q7KYU9
    Related
    ENSP00000350283.3, ENST00000357654.9
    Conserved Domains (4) summary
    smart00292
    Location:17581842
    BRCT; breast cancer carboxy-terminal domain
    cd00027
    Location:16501724
    BRCT; Breast Cancer Suppressor Protein (BRCA1), carboxy-terminal domain. The BRCT domain is found within many DNA damage repair and cell cycle checkpoint proteins. The unique diversity of this domain superfamily allows BRCT modules to interact forming homo ...
    cd00162
    Location:2368
    RING; RING-finger (Really Interesting New Gene) domain, a specialized type of Zn-finger of 40 to 60 residues that binds two atoms of zinc; defined by the 'cross-brace' motif C-X2-C-X(9-39)-C-X(1-3)- H-X(2-3)-(N/C/H)-X2-C-X(4-48)C-X2-C; probably involved in ...
    pfam12820
    Location:345507
    BRCT_assoc; Serine-rich domain associated with BRCT
  365. NM_007297.4NP_009228.2  breast cancer type 1 susceptibility protein isoform 3

    Status: REVIEWED

    Source sequence(s)
    BC072418, BU617173, BU679389, U14680
    Consensus CDS
    CCDS11459.2
    UniProtKB/Swiss-Prot
    P38398
    Related
    ENSP00000418775.1, ENST00000493795.5
    Conserved Domains (3) summary
    smart00292
    Location:17111795
    BRCT; breast cancer carboxy-terminal domain
    cd00027
    Location:16031677
    BRCT; Breast Cancer Suppressor Protein (BRCA1), carboxy-terminal domain. The BRCT domain is found within many DNA damage repair and cell cycle checkpoint proteins. The unique diversity of this domain superfamily allows BRCT modules to interact forming homo ...
    pfam12820
    Location:298460
    BRCT_assoc; Serine-rich domain associated with BRCT
  366. NM_007298.4NP_009229.2  breast cancer type 1 susceptibility protein isoform 4

    See identical proteins and their annotated locations for NP_009229.2

    Status: REVIEWED

    Source sequence(s)
    AC135721
    Consensus CDS
    CCDS11454.2
    UniProtKB/Swiss-Prot
    P38398
    UniProtKB/TrEMBL
    A0A024R1V0
    Related
    ENSP00000420705.2, ENST00000491747.6
    Conserved Domains (3) summary
    smart00292
    Location:654738
    BRCT; breast cancer carboxy-terminal domain
    cd00027
    Location:546620
    BRCT; Breast Cancer Suppressor Protein (BRCA1), carboxy-terminal domain. The BRCT domain is found within many DNA damage repair and cell cycle checkpoint proteins. The unique diversity of this domain superfamily allows BRCT modules to interact forming homo ...
    cd00162
    Location:2368
    RING; RING-finger (Really Interesting New Gene) domain, a specialized type of Zn-finger of 40 to 60 residues that binds two atoms of zinc; defined by the 'cross-brace' motif C-X2-C-X(9-39)-C-X(1-3)- H-X(2-3)-(N/C/H)-X2-C-X(4-48)C-X2-C; probably involved in ...
  367. NM_007299.4NP_009230.2  breast cancer type 1 susceptibility protein isoform 5

    See identical proteins and their annotated locations for NP_009230.2

    Status: REVIEWED

    Source sequence(s)
    BC072418, BU617173, BU679389
    Consensus CDS
    CCDS11455.2
    UniProtKB/Swiss-Prot
    P38398
    Related
    ENSP00000417148.1, ENST00000468300.5
    Conserved Domains (2) summary
    pfam00533
    Location:546619
    BRCT; BRCA1 C Terminus (BRCT) domain
    cd16498
    Location:1865
    RING-HC_BRCA1; RING finger, HC subclass, found in breast cancer type 1 susceptibility protein (BRCA1) and similar proteins
  368. NM_007300.4NP_009231.2  breast cancer type 1 susceptibility protein isoform 2

    Status: REVIEWED

    Source sequence(s)
    AC135721, BC072418, BC115037, BU617173, BU679389, U14680
    Consensus CDS
    CCDS11456.2
    UniProtKB/Swiss-Prot
    P38398
    Related
    ENSP00000418960.2, ENST00000471181.7
    Conserved Domains (4) summary
    smart00292
    Location:17791863
    BRCT; breast cancer carboxy-terminal domain
    cd00027
    Location:16711745
    BRCT; Breast Cancer Suppressor Protein (BRCA1), carboxy-terminal domain. The BRCT domain is found within many DNA damage repair and cell cycle checkpoint proteins. The unique diversity of this domain superfamily allows BRCT modules to interact forming homo ...
    cd00162
    Location:2368
    RING; RING-finger (Really Interesting New Gene) domain, a specialized type of Zn-finger of 40 to 60 residues that binds two atoms of zinc; defined by the 'cross-brace' motif C-X2-C-X(9-39)-C-X(1-3)- H-X(2-3)-(N/C/H)-X2-C-X(4-48)C-X2-C; probably involved in ...
    pfam12820
    Location:345507
    BRCT_assoc; Serine-rich domain associated with BRCT

RefSeqs of Annotated Genomes: Homo sapiens Annotation Release 110 details...Open this link in a new tab

The following sections contain reference sequences that belong to a specific genome build. Explain

Reference GRCh38.p14 Primary Assembly

Genomic

  1. NC_000017.11 Reference GRCh38.p14 Primary Assembly

    Range
    43044295..43125364 complement
    Download
    GenBank, FASTA, Sequence Viewer (Graphics)

Alternate T2T-CHM13v2.0

Genomic

  1. NC_060941.1 Alternate T2T-CHM13v2.0

    Range
    43902857..43983996 complement
    Download
    GenBank, FASTA, Sequence Viewer (Graphics)

Suppressed Reference Sequence(s)

The following Reference Sequences have been suppressed. Explain

  1. NM_007295.2: Suppressed sequence

    Description
    NM_007295.2: This RefSeq was permanently suppressed because only partial transcript evidence exists for this transcript variant, and its full-length exon combination is unclear.
  2. NM_007296.2: Suppressed sequence

    Description
    NM_007296.2: This RefSeq was permanently suppressed because there is no full-length transcript support for the exon combination of this variant.
  3. NM_007301.2: Suppressed sequence

    Description
    NM_007301.2: This RefSeq was permanently suppressed because currently there is insufficient support for the transcript and the protein.
  4. NM_007302.2: Suppressed sequence

    Description
    NM_007302.2: This RefSeq was permanently suppressed because only partial transcript evidence exists for this transcript variant, and its full-length exon combination is unclear.
  5. NM_007303.2: Suppressed sequence

    Description
    NM_007303.2: This RefSeq was permanently suppressed because the full-length sequence of this transcript variant is unavailable, and its full-length exon combination is unclear.
  6. NM_007305.2: Suppressed sequence

    Description
    NM_007305.2: This RefSeq was permanently suppressed because the full-length sequence of this transcript variant is unavailable, and its full-length exon combination is unclear.
  7. NM_007306.2: Suppressed sequence

    Description
    NM_007306.2: This RefSeq was permanently suppressed because currently there is insufficient support for the transcript and the protein.